These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9549967)
1. Cytochromes: a primer for child and adolescent psychiatrists. Oesterheld JR; Shader RI J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):447-50. PubMed ID: 9549967 [No Abstract] [Full Text] [Related]
2. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs. Kanner AM; Gidal BE Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-mediated drug interactions. Flockhart DA; Oesterheld JR Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):43-76. PubMed ID: 10674190 [TBL] [Abstract][Full Text] [Related]
5. Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk. Mula M; Monaco F; Trimble MR Expert Rev Neurother; 2004 Nov; 4(6):953-64. PubMed ID: 15853522 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and clinical significance of genetic variability in psychotropic drug metabolism. Brøsen K; Gram LF Psychopharmacol Ser; 1989; 7():192-200. PubMed ID: 2687857 [No Abstract] [Full Text] [Related]
8. Cytochromes and psychotropic drug interactions. Bates GD; Van Woerkom AE Br J Psychiatry; 1996 Nov; 169(5):670. PubMed ID: 8932910 [No Abstract] [Full Text] [Related]
9. Developmental pharmacology. van den Anker JN Dev Disabil Res Rev; 2010; 16(3):233-8. PubMed ID: 20981761 [TBL] [Abstract][Full Text] [Related]
10. Cytochromes in psychopharmacology. von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999 [No Abstract] [Full Text] [Related]
11. Interactions between anticonvulsant and psychoactive drugs. Monaco F; Cicolin A Epilepsia; 1999; 40 Suppl 10():S71-6. PubMed ID: 10609607 [TBL] [Abstract][Full Text] [Related]
12. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Alldredge BK Neurology; 1999; 53(5 Suppl 2):S68-75. PubMed ID: 10496236 [TBL] [Abstract][Full Text] [Related]
13. Special issues in the psychopharmacological management of Hispanic Americans. Marin H; Escobar JI Psychopharmacol Bull; 2001; 35(4):197-212. PubMed ID: 12397866 [TBL] [Abstract][Full Text] [Related]
14. Relevance of pharmacokinetics to prescribing in psychiatry. Ashton H; Harrison R Br J Hosp Med; 1994 Jun 1-14; 51(11):573, 576-80. PubMed ID: 7952746 [TBL] [Abstract][Full Text] [Related]
15. Therapy for neurobehavioral disorders in epilepsy. Devinsky O Epilepsia; 2004; 45 Suppl 2():34-40. PubMed ID: 15186343 [TBL] [Abstract][Full Text] [Related]
16. Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. Reimers A; Skogvoll E; Sund JK; Spigset O J Clin Psychopharmacol; 2005 Aug; 25(4):342-8. PubMed ID: 16012277 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and chirality in psychopharmacology. Baker GB; Coutts RT; Holt A Biol Psychiatry; 1994 Aug; 36(4):211-3. PubMed ID: 7986884 [No Abstract] [Full Text] [Related]
18. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence]. Hebebrand J; Gerlach M Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786 [No Abstract] [Full Text] [Related]
19. Pilot study to determine the interaction of oxiracetam with antiepileptic drugs. van Wieringen A; Meijer JW; van Emde Boas W; Vermeij TA Clin Pharmacokinet; 1990 Apr; 18(4):332-8. PubMed ID: 2108837 [TBL] [Abstract][Full Text] [Related]
20. ["Therapeutic drug monitoring", a strategy for improving drug safety in child and adolescent psychiatry and psychotherapy]. Gerlach M; Schulz E; Fegert JM Z Kinder Jugendpsychiatr Psychother; 2005 Jul; 33(3):157-8. PubMed ID: 16097263 [No Abstract] [Full Text] [Related] [Next] [New Search]